<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03398759</url>
  </required_header>
  <id_info>
    <org_study_id>FNPA2017</org_study_id>
    <nct_id>NCT03398759</nct_id>
  </id_info>
  <brief_title>Butorphanol Mitigate Emergence Agitation in Patients Undergoing Functional Endoscopic Sinus Surgery</brief_title>
  <official_title>Butorphanol Mitigate Emergence Agitation in Patients Undergoing Functional Endoscopic Sinus Surgery：a Randomized Control Double Blinded Clinical Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Emergence agitation is one of the common postoperative complications after functional
      endoscopic sinus surgery（FESS). The objective of present study is to explore the
      effectiveness of butorphanol in the alleviation of emergence agitation in patients undergoing
      Functional Endoscopic Sinus Surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Butorphanol is a mixed agonist-antagonist opioid with strong κappa-receptor agonist and weak
      mu-receptor antagonist activity. It is commonly used for the management of cancer,
      postoperative, gynecologic, and obstetric pain. Additionally, Butorphanol has less
      respiratory depression and sedation effects, which make it may become a good medicine to
      alleviate the agitation. However, there is no clinical evidence to confirmation of such
      effectiveness of butorphanol. The objective of present study is to explore the effectiveness
      of butorphanol in the alleviation of emergence agitation in patients undergoing Functional
      Endoscopic Sinus Surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Emergence agitation incidence</measure>
    <time_frame>1 hour in the post anesthesia care unite(PACU)</time_frame>
    <description>Emergence agitation incidence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MAP</measure>
    <time_frame>1 hour in the post anesthesia care unite(PACU)</time_frame>
    <description>The mean arterial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>1 hour in the post anesthesia care unite(PACU)</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of recovery -40 questionnaire</measure>
    <time_frame>24h after operation</time_frame>
    <description>Measurement of quality of recovery with QoR-40</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Agitation</condition>
  <arm_group>
    <arm_group_label>Butorphanol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Butorphanol 20ug/kg , anesthesia induction，Intravenous injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline 5ml ， anesthesia induction，Intravenous injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Butorphanol</intervention_name>
    <description>Butorphanol IV injection</description>
    <arm_group_label>Butorphanol</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt;=18 years,&lt;=65years;

          2. height 150-180 cm;

          3. weight 55-80 kg;

          4. Signed the inform consent

          5. American Society of Anesthesiologists classification I to II

          6. Select to functional endoscopic sinus surgery

        Exclusion Criteria:

          1. Existing cerebral disease, or have a history of neurological and psychiatric diseases
             including Alzheimer Disease, stroke, epilepsy and psychosis;

          2. Several audition or vision disorder;

          3. Unwillingness to comply with the protocol or procedures.

          4. Can not communicated with Chinese Mandarin

          5. Existing bradycardiac arrhythmia（Heart rate &lt;60 bpm for any reasons）

          6. Existing gastrointestinal ulcer

          7. Existing urinary incontinence

          8. Existing asthma or chronic obstructive pulmonary disease

          9. Allegory to Butorphanol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weifeng Yu, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Anesthesiology Department Renji Hospital, Shanghai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaorong Huai, MS</last_name>
    <phone>+8613818003683</phone>
    <email>smile_huai@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Diansan Su, MD</last_name>
    <phone>+8618616514088</phone>
    <email>diansansu@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Renji Hospital, Shanghai Jiao Tong University, School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaorong Huai, MS</last_name>
      <phone>+8613818003683</phone>
      <email>smile_huai@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Diansan Su, M.D., Ph.D</last_name>
      <phone>+8618616514088</phone>
      <email>diansansu@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Xiaorong Huai, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2018</study_first_submitted>
  <study_first_submitted_qc>January 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2018</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RenJi Hospital</investigator_affiliation>
    <investigator_full_name>Xiaorong Huai</investigator_full_name>
    <investigator_title>resident physician</investigator_title>
  </responsible_party>
  <keyword>Butorphanol</keyword>
  <keyword>Functional endoscopic sinus surgery</keyword>
  <keyword>Emergence agitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Butorphanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

